Despite this, healthy carriers of PRKN heterozygote protein altering variants have shown increased serum levels of pro-inflammatory cytokines (e.g., IL-6, IL-1β, CCL2) similar to those observed in homozygote PRKN protein altering variant carriers with PD (17). This evidence concerns the gene PRKN and Parkinson disease.